Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon Alpha

NCT00031018 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

NIH

Sponsor class

Conditions

Memory Disorders
Alzheimer's Disease

Interventions

DRUG: Aricept
DRUG: IFN-alpha2A

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]